COVID-19 and Use of Emergency Vaccination in Pregnancy

Abstract

Introduction: COVID-19 is a respiratory infection of viral origin that was diagnosed for the first time at the end of 2019 in China. In Cuba, pregnant women were part of the population group with the highest morbidity.
Objective: To present updated information on COVID-19 and the relationship with the use of emergency vaccination during pregnancy.
Methods: A search was performed in SciELO, PubMed, Medline, and DynaMed, using the terms SARS-CoV-2, COVID-19, vaccines, and pregnancy. One hundred twenty three documents were retrieved, 36 of them were castoff because they did not correspond with the theme of this review. Out of the remaining 87, 19 were not useful because the full text was not accessible and 23 were not
considered reliable due to the methodology used. We selected 35 out of the remaining.
Conclusions: The physiological changes of pregnancy put the pregnant woman affected by COVID-19 at greater risk for severe or critical stages of the disease, which can lead to a high lethality. Espirta study designed by the Genetic Engineering and Biotechnology Center of Havana is part of the surveillance strategy and it will evaluate the immunogenicity achieved by pregnant women and their newborns.